IL6 and viral infectious disease: Elevated levels of interleukin-6 (IL-6), recognized as the major mediator of the inflammatory and immune response initiated by viral infection, have been observed in over 50% of patients with COVID-19 and have been associated with respiratory failure, the need for mechanical ventilation and/or intubation, and high mortality in these severe forms [285].